Top 100 Finalists

Acorai is revolutionizing heart failure management through non-invasive cardiac and pulmonary pressure sensing. Leveraging a proprietary multi-sensor platform - powered by machine learning and trained on data from over 2,000 patients - Acorai provides accurate, real-time estimates of right atrial and pulmonary capillary wedge pressures. This enables clinicians to make faster and more informed treatment decisions across emergency, inpatient, and community care settings. Demonstrated to outperform existing non-invasive methods, Acorai’s device improves patient outcomes while reducing hospital readmissions and overall costs. The company holds several patents, is FDA Breakthrough Device designated, and is progressing toward US and EU regulatory approvals. With a strong clinical and technical team, Acorai aims to bring precision diagnostics to the bedside and reshape the heart failure care pathway.

Acorai is revolutionizing heart failure management through non-invasive cardiac and pulmonary pressure sensing. Leveraging a proprietary multi-sensor platform - powered by machine learning and trained on data from over 2,000 patients - Acorai provides accurate, real-time estimates of right atrial and pulmonary capillary wedge pressures. This enables clinicians to make faster and more informed treatment decisions across emergency, inpatient, and community care settings. Demonstrated to outperform existing non-invasive methods, Acorai’s device improves patient outcomes while reducing hospital readmissions and overall costs. The company holds several patents, is FDA Breakthrough Device designated, and is progressing toward US and EU regulatory approvals. With a strong clinical and technical team, Acorai aims to bring precision diagnostics to the bedside and reshape the heart failure care pathway.

AI-vBrain pioneers a dual-platform model that bridges AI-powered MRI enhancement with open-science accessibility. Our B2C platform, NeuroData Vault, provides researchers with secure access to a unique repository of advanced brain MRI datasets, synthetically generated from widely available T1-weighted or non-contrast CT scans using our proprietary AI. Scientists can download multiparametric outputs (e.g., FLAIR, DTI, SWI) that typically require costly, hard-to-obtain scans, accelerating neurological research while ensuring patient privacy through synthetic data generation.For healthcare providers, we deliver turnkey B2B solutions through OEM partnerships with MRI manufacturers — embedding our AI directly into scanner software — and through subscription-based integrations with hospitals. This allows clinics to produce 7+ diagnostic sequences from a single scan, either via cloud or on-premise deployment, streamlining workflows and reducing scanning costs.This dual-platform model monetizes our AI in two ways: first, by democratizing access to rare data for academia; second, by optimizing clinical operations for enterprise partners.

We help insurers to save billions of euro by keeping CHF and COPD patients out of hospital thanks to our patented telemedical device. The global market for chronic heart failure diagnosis and treatment exceeds $45B, with 80% of costs tied to hospitalizations due to inadequate diagnostic tools. Our patented system enables rapid heart failure assessment, reducing diagnosis time from weeks to minutes. The EFM system consists of three components: The device - small, portable - takes signals from the patient's body and transmits them to the SaaS platform - collects the downloaded data and prepares it for medical evaluation with the possibility of sending it to hospital systems. Algorithms - active in the cloud - analyze subtle anomalies and present them in a way that helps identify cardiac problems. The Mudisococard system perform simultaneous measurement of different types of signals in a three-dimensional way, synchronously, providing previously unavailable medical information.

E-SENSE is a pioneering MedTech startup founded in Hong Kong, specializing in the development of next-generation biomedical imaging systems for early detection and monitoring of vital organ health. E-SENSE aims to revolutionize preventive healthcare with its Electrical Impedance Tomography (EIT) technology, advanced medical grade micro-electronics, state-of-the-art EIT image processing pipelines and cloud-based AI-enabled clinical metrics prediction, designed to offer affordable, accessible, and effective organ screening solutions for both clinical and home use. EIT is an established bio-imaging technology with good safety profile and broad application potential for disease screening and monitoring. We are making EIT accessible in small clinic and eventually home settings to serve a broad population.

Eyerising International (ERI) is a pioneering digital health company based in Melbourne, Australia, focused on tackling the global childhood myopia epidemic. ERI’s flagship product, the Eyerising Myopia Management Device, delivers Repeated Low-Level Red-Light (RLRL) therapy, a clinically proven, non-invasive treatment to slow and, in some cases, reverse myopia progression in children aged 3–16. The device is TGA-, CE-, and MHRA-approved and backed by robust peer-reviewed research, offering unmatched safety and efficacy. Unlike traditional optical treatments, ERI’s home-use digital solution empowers families to manage myopia conveniently while enabling clinicians to track real-time compliance via a cloud-based platform. With approvals in over 40 countries and presence in 10+ markets, ERI is scaling rapidly across Asia, the Middle East, and Europe. As the first company outside China to commercialize RLRL therapy globally, ERI is redefining digital eye health and aims to become the standard of care for pediatric myopia management worldwide.

Goldilocks uses smart clothing and AI to deliver proactive, personalized care—like a 'ChatGPT' for wellbeing—already transforming lives globally.

InSilicoTrials is a leading European and global innovator in digital healthcare transformation. Founded by experts in life sciences, cybersecurity, and digital innovation, we offer a cloud-based simulation platform that accelerates drug development using advanced AI and in silico techniques. Our tools help Pharma, Biotech companies, and researchers predict compound safety and efficacy, reducing reliance on costly and lengthy clinical trials. The platform includes digital twins, virtual patients, and privacy-preserving synthetic populations to simulate diverse disease conditions and support decision-making across bench, preclinical, and clinical stages. We offer a wide array of models—from mechanistic to AI-driven and hybrid—streamlining R&D processes. Our platform's capabilities have led to clinical trial designs accepted by the European Medicines Agency (EMA). With over 70 scientific partners and hundreds of integrated models, InSilicoTrials empowers faster, more accurate, and cost-effective drug development across the global life sciences ecosystem.

InSimili is a biotech startup revolutionizing drug discovery with a patented biomaterial that precisely regulates oxygen, glucose, and pH in standard cell culture plates. Our OxygenControl plates recreate disease-relevant microenvironments in vitro, enabling more predictive and scalable preclinical testing. Unlike complex organ-on-chip systems or bulky hypoxic hoods, our solution is affordable, easy to use, and compatible with existing lab protocols. By bridging the gap between in vitro and in vivo conditions, we reduce false positives, accelerate development timelines, and cut R&D costs, potentially saving up to €2 billion per drug. We are running over 20 pilot studies with leading universities, CROs, and pharma, with early revenues and strong validation. With a strong team and a defensible IP portfolio, our goal is to establish “in simili” experimentation as a new standard in drug discovery, starting with oncology, where the demand for predictive, scalable preclinical models presents a significant market opportunity.

KA has created the world’s first Spectral (Color) x-ray system that can separate and identify different materials, such as soft tissue and bone. Our clinical data has shown to detect more pneumonia, pneumothorax, cancer, cardiac disease and even show bone density measurements. We have new data that shows a high correlation to detecting coronary arteries disease, as well as CT, which is will save lives. We use the same x-ray radiation dose and do not change the work flow. We are approved for sales in 11 global jurisdictions, including USA, Europe, Canada, Taiwan, Philippines, Indonesia. We recently signed an MOU with Canossa Hospital in Hong Kong and expanding our efforts in Asia.

MICA Artificial Intelligence Ltd. is an Israeli med-tech company revolutionizing breast cancer diagnostics through advanced AI. Our proprietary solution, M2C, is designed to detect cancer in women with dense breast tissue—an underserved population—without the need for contrast-enhanced imaging. MICA is ISO13485 certified, with regulatory approvals in Israel and Argentina, and is actively pursuing FDA clearance. In collaboration with leading hospitals such as Sheba Medical Center and ARC, MICA delivers a non-invasive, cost-effective diagnostic tool that integrates seamlessly into radiology workflows. We are now expanding into Asia, where dense breast prevalence is high and demand for scalable, precise early detection is growing rapidly. With a B2B model targeting hospitals and imaging centers, MICA provides a game-changing platform to improve outcomes and optimize radiology resources across the region.

MITAS Medical provides innovative tele-eye care solutions, using mobile slit lamps and telemedicine to make eye care accessible globally.

PITTAN Inc. is transforming the future of digital health through a compact bioanalyzer, “Pitagoras”, which enables non-invasive, on-site analysis of amino acids in sweat within 10 minutes. Designed with cutting-edge microfluidic and enzyme technologies, the platform provides real-time insight into inner health conditions for personalized wellness optimization. Initially targeting the wellness and fitness markets, we are expanding to detect hormones, inflammatory and aging markers, using saliva and hair as new sample types. Our mission aligns with the EPIC Digital Health Tech track by empowering preventive health and personalized care through scientific data. With a strong foundation in research, intuitive UI/UX, and a scalable business model, we aim to expand from Japan into the GBA and global markets, contributing to the evolution of healthcare and self-care worldwide.

Bringing ultrasound to the mass market with AI. Converting ultrasound into the largest high-quality imaging data source on early-stage disease.

RBS is developing platform technologies in Microfluidic cell sorting/analyzing equipment and proprietary Microencapsulated mini-Biosystems (MEBS), with wide ranging applications. These include innovative bioengineering approaches for major 21st century industries such as cell therapy and Regenerative medicine, Valuable bio-chemicals for synthetic biology, and a cutting edge time-resolved immune profiling and cancer screening system for oncology drug discovery and therapy. Our groundbreaking projects are supported by HK-govt. funded ITF and RIF grants, in collaborative R&D efforts with CityU of Hong Kong. RBS is also collaborating with various leading industrial partners to advance our technology such as Asia Regenerative Medicine, CityU, Allied Flow JP, and Tencent AI Labs. We are building the GBA’s leading AI-driven intelligent biological analysis platform, with a target to create a global hub. Lastly, we will have numerous equipment products and contract services are launching in 2025 to the regional and then global biotech ecosystem

Since less than 10% of gene therapies in clinical trials reach the market, there is a dire need to increase the efficacy of these drugs to help patients. Re:Pair Genomics uses AI to make gene therapies safer and more efficacious, by targeting specific organs and cell types of interest. Our proprietary software is trained by multiple datasets and determines the crucial DNA sequences needed to construct a mini-GPS that fits inside a gene therapy product, controlling the location of activation. The designs can be generated within a day, a process that traditionally requires 3-6 months for scientists to perform manually.

At RNT Health Insights, we are dedicated to enhancing gastrointestinal diagnostics with cutting-edge technology. We are developing Al-assisted diagnostic tools to aid endoscopists in the real-time detection of upper gastrointestinal lesions, including early gastric cancer and associated malignant lesions. Our Early Gastric Cancer detection technology, recognized with the US FDA Breakthrough Device Designation, aims to enhance diagnostic precision and improve patient outcomes. By seamlessly integrating Al with endoscopy, we strive to reduce missed diagnoses and improve patient prognosis through timely intervention. We are developing AI-assisted solutions to aid endoscopists in the real-time detection of upper gastrointestinal lesions, including early gastric cancer. Our technology has received the prestigious US FDA Breakthrough Device Designation, underscoring its potential to revolutionize early diagnosis and treatment.

Sonaro Inc. is a Canadian digital health company revolutionizing stroke prevention through AI-powered vascular imaging. Our flagship technology, Vaso3D, transforms standard 2D ultrasound into fully automated 3D models of the carotid arteries—where most stroke-causing plaques originate. This enables earlier, more accurate risk assessment in a cost-effective, non-invasive, and scalable way. Unlike traditional imaging methods that are reactive, time-intensive, and reliant on highly trained personnel, Sonaro’s solution enhances diagnostic precision while improving accessibility.

SuperVision Medicine is an AI-powered medical device startup developing next-generation ophthalmology screening tools for early detection of retinal and neurological diseases. The company’s flagship product is a portable, high-resolution fundus imaging device integrated with advanced deep learning algorithms. It allows for automated screening of over 300 diseases, including diabetic retinopathy, glaucoma, and Alzheimer’s-related conditions. Designed for accessibility and mobility, the device can be used by non-specialists and integrated into community health systems. SuperVision is building a massive multimodal database with over 6 million retinal images and aims to become the global leader in "ocular biomarkers" for systemic health. The team includes experts from Peking University, Tsinghua University, and industry veterans in ophthalmic imaging and AI.

tenacio transforms cardiovascular care through AI-powered clinical decision support to improve care quality, reduce complications and cost.

Ascendsure is an AI-powered risk-based drone insurance pricing engine. Existing drone insurance products take a “one-size fits all” approach to pricing without regard for each flight trajectory specific risks. Our engine takes a three steps approach: (1) Drone operator provides vehicle specs and flight trajectory; (2) AI engine computes flight risks and a quant finance model calculates the insurance analytics; and finally (3) We offer an on-demand insurance quote. The B2B target market of our engine includes insurance companies, drone manufacturers and logistics companies. Our team consists of PhD and masters graduates from global top 10 universities. Together, we have a combined 40+ years of experience in academia, quant finance and big tech.

Belli builds air cargo software for airlines. The problem we solve is that airlines fly with the bottom of the plane 85% empty.

Life insurance that prevents and manages diseases. A digital first approach powered by AI underwriting that offers individuals with chronic diseases dynamic, convenient and affordable life insurance. It also gives customers an AI-powered health coach that engages and rewards customers for improvements in their health. Rewards are in the form of discounted premiums, access to discounted health products and increased insurance terms. We call the product a longevity subscription. We operate as a Managing General Agent in the UK. Our fronting insurance partner is Shepherd's Friendly and our reinsurance partner is Gen Re. We aim to launch other insurance products in the future such as critical illness and travel insurance. We're keen to expand into Asia specifically Hong Kong where the prevalence of chronic illnesses are high and life insurance penetration is high.

Through blockchain and other emerging technologies, the path to globalization and connectivity is accelerating— yet barriers still exist.

Deploy Intelligence isn't just another analytics tool--we've built an AI-powered expert intelligence network that makes traditional due diligence look like the Stone Age. Our Cadet platform slashes through pitch decks and market signals with surgical precision, delivering 80% faster screening that lets private investors pounce on opportunities while competitors are still reading PDFs. But that's just the opening act. Our game-changing Pathfinder tool demolishes the barriers between investors and industry insiders. No more six-figure expert network fees. No more weeks-long delays. Just direct, frictionless access to the brilliant minds who know exactly which startups will dominate tomorrow. Our proprietary reputation algorithm ensures you're only connected with experts who deliver, creating a virtuous cycle where the smartest voices rise to the top. The numbers? 40% lower due diligence costs. 3x higher quality deal flow. Deploy Intelligence: Because in private investment, the firm with the best intelligence wins. Every. Single. Time.

Divizend is a German FinTech revolutionizing the way investors reclaim foreign withholding tax on dividends. Receiving cross-border dividends often results in double taxation and a complex, paper-based reclaim process that many investors avoid altogether. Our intuitive, automated software transforms this painful experience into a seamless, end-user-friendly journey—saving investors significant time and money. With just four easy steps, users connect their securities portfolio, gain a transparent overview of their dividend refunds, and submit claims with a few clicks. Backed by an API-first business model and strong partnerships with major players like KPMG and the Swiss Stock Exchange, Divizend is scaling rapidly across Europe and expanding into Southeast Asia. Addressing an untapped $100 billion market, with $20 billion still unreclaimed annually, Divizend offers a highly competitive 17.5% transaction-based fee. We are fully bootstrapped, with a world-class team and a lean, scalable model ready to make global tax reclaim effortless.

Doxa Connex streamlining processes from procurement to payment workflow and embedded deep-tier financing to faster access to cash flow.

Franc is South Africa's #1 digital financial advisor. We help clients save money and build wealth through simple, smart financial advice. Through Franc clients can get 5% cashback on their insurance premiums and access the best funds, from emergency savings to offshore ETFs, without minimums or restrictions all for just a simple, all-in annual fee of 1%. We turn financial stress into financial freedom. Our revenue has doubled in the last 6 months with a 99% customer retention rate. We're 50% cheaper than traditional advisors and accessible 7 days a week conveniently on your mobile device. Our mission is to help a million investors build wealth in the next 3 years.

As a company researching web3 and a new economy, we are focusing on building a Non-financial Real World Asset (RWA) Exchange, pioneering a new category of tokenized assets that are not regulated as securities, commodities, or financial products. Our platform enables compliant, secure, and scalable trading of unique real-world interests such as collectibles, cultural goods, and ecosystem-based tokens. Founded by a team with deep roots in blockchain, traditional finance, and digital asset infrastructure, our company operates across Hong Kong and Mainland China. We have successfully launched and operated NFT platforms in both regions, building strong regulatory relationships and a robust user base. Our organization is structured to support rapid innovation, regulatory compliance, and cross-border collaboration.

Investbanq is an AI-powered wealth operating system for family offices, asset managers and banks. The platform addresses growing dissatisfaction with traditional wealth managers due to the lack of comprehensive digital services, limited access to investments, and general operational inefficiencies by offering a Digital Family Office (DFO) suite. This service provides personalized and cost-effective wealth management tools through an intuitive interface, incorporating AI-driven advisory capabilities, reporting, and analytics. Investbanq’s Wealth Operating System (WealthOS) also supports financial institutions in transitioning to AI-enabled WealthTech platforms, catering to the technological expectations of affluent clients amid a generational wealth transfer. At Investbanq, our mission is to redefine the future of wealth management by building a more inclusive financial ecosystem. We are committed to breaking down barriers and empowering institutions to connect generations of investors—from seasoned professionals to emerging digital natives—fostering sustainable growth and innovation across Asia, MENA, and beyond.

MiKashBoks is a fintech platform bridging the gap between the informal sector and formal financial services in sub-Saharan Africa, where 80% of the population works informally and lacks access to banks or credit. Our app allows users to save safely via mobile, earn interest, and build a financial profile to access loans and other services—empowering them to grow businesses and secure better futures. We operate a commission-based model with recurring revenue through partner connections. Rather than disrupt the system, we act as the oil that makes it work. Launched in Sierra Leone less than 18 months ago, MiKashBoks has over 15,000 users and is expanding through new partnerships in Nigeria.

Nx.one is an AI-powered trading platform offering smart profit strategies and a secure, efficient trading experience.

NodeShift is a sovereign AI cloud platform that lets enterprises and governments deploy powerful AI models anywhere—public cloud, private data center, or air-gapped bare metal—with a single click. Our control plane orchestrates compute VMs, GPU clusters, storage and networking across a decentralised mesh of partner data centres in the GCC, EU and US, delivering hyperscaler-grade performance without surrendering data residency or compliance. Customers can spin up more than 140 pre-tuned LLMs and agent frameworks, integrate their own models, and manage access through fine-grained RBAC and audit logging that satisfies SOC 2, ISO 27001 and local data-protection laws. Backed by $3.2 million in seed funding, our Oxford- and ex-Microsoft-led team is redefining how mission-critical organisations run AI at scale.

Pyxis is a Singapore-based fintech platform transforming treasury management in emerging markets, beginning with high-volume Chinese importers operating in Africa. It tackles cross-border payment challenges—such as currency mismatches, liquidity constraints, and compliance risks—by offering real-time FX conversion, verified transaction data, and automated reconciliation. With over $257 million in transactions processed across Nigeria, Ghana, and Tanzania, Pyxis targets the $180 billion China–Africa trade corridor. The platform accelerates settlements, unlocks scalable financing, and bridges critical infrastructure gaps. By streamlining international payments, Pyxis simplifies global trade while promoting financial inclusion in underserved regions. It is redefining how businesses in frontier economies manage treasury operations, enabling them to grow with confidence in complex international markets.

Spendbase is a spend management platform designed to break your old habits around business expenses and introduce a radically different way of building cost efficiency.

SPIN Analytics is a pioneering fintech company transforming credit risk management with its flagship platform, RISKROBOT 2.0. Leveraging Agentic AI and advanced automation, SPIN Analytics accelerates and enhances the development, validation, and deployment of credit risk models, enabling banks to meet regulatory standards like Basel III with speed and accuracy. RISKROBOT 2.0 dramatically reduces model development time—from 6–12 months to just a few weeks—while ensuring full transparency, explainability, and compliance. Trusted by Tier 1 financial institutions, SPIN Analytics empowers credit risk and compliance teams to make faster, data-driven decisions, cut operational costs, and scale securely in the cloud. With a strong foundation in regulatory technology and a vision for AI-driven transformation in banking, SPIN Analytics is shaping the future of risk modeling for global financial institutions. In June 2025, SPIN Analytics was named a winner of the McKinsey Challenge, selected among Europe’s top scale-ups.

TalentHero is a global Employer of Record (EOR) and HR platform that helps companies hire talent internationally without setting up legal entities. We manage everything from employment contracts and compliance to payroll and benefits, enabling businesses to scale quickly, compliantly, and cost-effectively. Our solution is ideal for startups and growing companies looking to access global talent pools without the overhead of local infrastructure. With TalentHero, businesses can onboard remote employees in over 100 countries, ensuring full legal compliance and local expertise. Whether you're expanding into new markets or building a remote-first team, TalentHero streamlines the entire employment process while reducing administrative burden.

Transak powers global financial applications and money flows through its stablecoin-payment APIs, enabling seamless and compliant fiat-to-crypto transactions. Regulated in the USA, Canada, UK, Europe, India, and soon Hong Kong, Transak provides modular and secure infrastructure that simplifies the complexities of onboarding users, conducting KYC, managing compliance, and mitigating fraud. Its powerful suite of APIs enables developers and fintech platforms to integrate fiat-to-stablecoin onramps, user authentication, and risk management tools with ease. Transak’s infrastructure supports fast, secure, and scalable operations across jurisdictions, helping companies enter new markets and meet regulatory requirements with confidence. With a strong focus on compliance and user experience, Transak is trusted by over 450 partners worldwide, including leading Web3 and fintech platforms such as MetaMask, Ledger, Immutable, and Trust Wallet. Whether you're building a wallet, exchange, or app, Transak provides the tools to move money globally and compliantly.

Vigilant AI was founded by AI, data security, and accounting experts to automate financial data preparation quickly and securely to allow financial professionals in audit and enterprise to analyze, audit and make decisions more efficiently and effectively in a timely basis. We leverage the latest AI and Machine Learning techniques to automatically create document data models and extract data from business process documentation, and cross correlate this information against all relevant accounting entries. The secure reusable and recallable curated data allows users to automate transaction verification, audit testing and provide more timely insights for reporting and business decision making. Secure clean data is a precursor to further allow the application of LLMs and generative AI to maximize the value of an organizations most valuable asset - data.

Expediente Azul is a fintech SaaS platform revolutionizing document-intensive processes for loans, insurance claims, and KYC/AML compliance. By automating document collection, validation, and follow-up, it slashes processing time from 57 to 17 days and reduces customer abandonment by 58% to 25%. The AI/ML-powered solution integrates with blockchain, CRM systems, and government databases (e.g., Mexico’s NOM 151) to ensure real-time tracking, multilingual support (English/Spanish/Portuguese), and fraud detection.

Apolownia is a mission driven nature tech company specializing in the development and financing of certified climate contribution projects. We focus on restoring and reforesting degraded coastal ecosystems such as mangroves, seagrass meadows and peatlands, due to their unique potential for carbon sequestration, biodiversity support and climate resilience. Our objective is to enhance both livelihoods and ecosystems, especially in Southeast Asia, by leveraging robust AI and machine learning technologies to support large scale wetland restoration. Apolownia delivers turnkey nature based solutions by integrating ecological science, remote sensing and financial structuring. Our platform ensures transparency, impact and credibility across the carbon value chain.

CERT Systems produces essential chemicals without fossil fuels. Through a process called Direct CO2 Electrolysis, we convert carbon dioxide emissions into high value chemicals such as ethylene. Ethylene is the world's most widely used organic chemical with an annual market of $200B. We enable a drop-in, low-carbon solution for the value chains that rely on ethylene, including plastics, textiles, and fuels. We were finalists in the $20M NRG COSIA Carbon XPRIZE, where we performed the first demonstration of industrial CO2 into ethylene. We are supported by the Breakthrough Energy Fellowship, RMI Third Derivative, and Canadian federal granting agencies, with over $6.5M in non-dilutive funding raised.

Critical. is a green tech company transforming the world’s hardest-to-recycle plastics into beautiful, circular materials for the built environment. Our flagship product, Cleanstone, is a range of high-performance, 100% recycled plastic panel that replaces virgin, high-emission materials like MDF, plywood, engineered stones and acrylic. Verified to emit 1,250x less compared to virgin materials, Cleanstone is used by leading brands such as BNZ, Fonterra, and The Warehouse Group. We’re closing over NZD $17M in contracts, operate at commercial scale, and offer a global-first buyback programme that enables closed-loop reuse.

EcoBean offers sustainable solutions for the coffee industry by transforming spent coffee grounds into valuable, eco-friendly ingredients. Instead of allowing coffee waste to contribute to environmental issues, EcoBean upcycles these grounds for use in the food, cosmetics, and packaging sectors. Their innovative process not only reduces waste but also supports the circular economy by reintroducing used materials into production cycles. EcoBean's products help companies lower their carbon footprint while promoting sustainability across industries. With a mission to make the coffee industry more environmentally responsible, EcoBean demonstrates how waste can become a resource. Their work reflects a broader commitment to green innovation and sustainable development. Learn more about their solutions and environmental impact at ecobean.pl.

Frass Pte Ltd is a Singapore-based agritech startup focused on transforming high-moisture, homogeneous food waste—such as fish offal, okara, spent grain, and brewery by-products—into sustainable animal feed using proprietary enzyme hydrolysis and bio-fermentation. Our low-energy, oven-free process significantly reduces moisture content and enhances digestibility, offering a climate-resilient alternative to imported soy and fishmeal. With R&D headquartered in Singapore, Frass operates through joint ventures with local partners across Indonesia, Vietnam, Cambodia, and Scotland. We empower smallholder and mid-sized farmers with affordable, locally produced feed, while helping regional industries reduce food waste and greenhouse gas emissions. Our business model prioritizes local production for local consumption, integrating circular economy principles and inclusive community impact into every stage of operation.

Gaiamesh is an AIoT-based climate tech company that aims to solve the widespread problem of overly complex building automation to make a dent on the global carbon curve. Our leadership team of experts in building energy efficiency and AIoT from leading companies including Disney, Bosch, Apple, and McKinsey. The Gaiamesh Platform is a wireless, plug-and-play smart building control system that makes it easy for building owners to save energy. By unlocking energy savings in operational buildings through rapid energy-efficiency retrofits, we can create a $150B dollar market. Our unique decentralized mesh control technology enables fast, stable and secure wireless control, patented in USA and China, with a proven track records with 250+ projects across 5 countries in APAC. Key clients include Starbucks, Disney, NYU Shanghai, and Wanda.

Many organizations face challenges in harvesting renewable energy in urban area due to high initial cost, inefficiencies, and lack of access to reliable technology. Our technology aims to tackle these challenges head-on. HydroVigor® (Hydropower Recycle System) unlocking massive untapped hydropower in Urban buildings’ water tank. Turn water tank to a hydropower plant in buildings. Just well use the innate resources in our buildings. Interdisciplinary technology is used, included hydrodynamic, electrical, hydropower, building and construction, manufacturing design and materials technologies. HydroVigor® is novel hydro system which generate green electricity as long as water flow. When water is pumped into water tank, water will pass through HydroVigor. Green electricity that was generated can be transfer back for the buildings’ use. Special material is used that is durable and no reaction with sea water, cleansing water etc. Robust design for on-site hydropower recycling.

Helix Carbon produces next-generation electrolyzers that convert point-source CO₂ into valuable industrial chemicals directly at the site of emission. Our proprietary catalyst coatings offer breakthrough stability and performance in harsh, mixed-gas environments, allowing operation without the need for expensive, energy-intensive carbon capture systems. By tuning the ratio of carbon monoxide and hydrogen produced, our systems generate drop-in, carbon-neutral reducing gases that are chemically identical to fossil-based alternatives. Our initial focus is on decarbonizing the global iron and steel industry, one of the largest industrial emitters, by enabling existing plants to cut emissions without major infrastructure changes. Helix Carbon delivers a scalable solution to industrial decarbonization by replacing fossil inputs, capturing waste carbon, and creating a closed-loop system for heavy industry.

Luquos Energy creates the first sulfur-based flow battery energy storage system in the world. The battery stores energy in earth-abundant sulfur active materials and nonflammable water-based electrolytes, which costs only 1/2 of Li-ion and 1/4 of vanadium flow battery. By innovation on membranes and catalysts, we solved critical issues of sulfur crossover and slow kinetics, that enables battery lifetime over 15 years. The technology is promising for long-duration, low-cost and eco-friendly energy storage, including renewable energy storage, data center back up power source, EV solar charger etc. Luquos Energy has launched the world’s first commercial polysulfide flow battery system, branded as LEAPLUG™. This system has been deployed at an EV charging station in Shenzhen, China, which strategically charges and stores electricity during off-peak, low-cost hours and discharges it during high-demand, peak-rate periods. This approach not only saves electricity costs but also alleviates strain on the power grid.

Plantible Foods is a vertically integrated ag-tech company that grows lemna (duckweed) at scale and turns it into Rubi™, a native RuBisCO protein that outperforms eggs, dairy, and synthetic emulsifiers on functionality, nutrition, and cost. Our closed-loop aquafarms recycle >95 % of water, run on renewable power, and valorize every co-product as animal feed, fertilizer, or energy, driving toward net-zero operations. The first commercial module in Eldorado, Texas already produces food- and cosmetic-grade Rubi with 45-50% gross margins and a clear path to cash-flow breakeven. Target markets span geriatric nutrition, bakery, confectionery, and personal care, unlocking multi-billion-dollar opportunities while displacing carbon-intensive animal proteins and petrochemical polymers.

Qarbotech is established in response to the founders’ concern about the unsustainable direction of modern agriculture. Faced with the growing demand for food, farmers are pressured to maximize yield on increasingly degraded land. The conventional reliance on fertilizers and pesticides has only worsened soil health and environmental conditions. Determined to drive change, the founders developed a new approach by leveraging nanomaterials made from agricultural waste through an acid-free, green production process. This led to the creation of environmentally responsible agricultural inputs that support circular economy. Our flagship product enhances photosynthesis efficiency for plants, helping crops absorb more light energy and CO2, boosting yields even under suboptimal conditions. Our pilot projects in Indonesia and Malaysia showed 20-40% yield increase across 2500 hectares, delivered up to USD 300 additional income per hectare of rice farmland. With broader adoption, we can help strengthen food security, improve farmer livelihoods, and reduce agriculture’s environmental footprint.

Sargassum Eco Lumber addresses the global crisis of Sargassum inundation affecting coastal areas worldwide by transforming this invasive, carbon-sequestering seaweed and recycled plastics into sustainable, high-performance building materials. Our patented, chemical-free process produces a durable composite that is water, pest, rot, and rost resistant. We offer a cost-competitive alternative to traditional lumber without compromising on performance, while reducing plastic waste, deforestation, and embodied carbon. Our versatile material is ideal for applications such as construction panels, pallets, decking, flooring and more. By turning an environmental threat into a scalable, climate-positive solution, we drive innovation in sustainable construction and advance the blue and circular economy.

Lithium-ion batteries are the power source behind countless devices across the globe, from smartphones and laptops to electric vehicles and energy storage systems. As demand for these batteries continues to grow, so too does the importance of ensuring their safety. Unfortunately, lithium-ion batteries can pose serious risks due to inherent manufacturing defects or accidental damage, which can result in dangerous fires or explosions. Soteria Battery Innovation Group, together with its industry-wide consortium, is committed to enabling inherently safe batteries everywhere. Soteria’s innovative and proven technology ensures that batteries continue to function safely even after damage, transforming potential disasters into manageable maintenance events.